Article Details

Sarepta Stock Is Down 57% This Year. Why the Biotech Could Make a Comeback. | Barron's

Retrieved on: 2021-08-24 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

Sarepta Stock Is Down 57% This Year. Why the Biotech Could Make a Comeback. | Barron's. View article details on hiswai:

Excerpt

The funds haven't covered themselves in glory, either, but at least the iShares Biotechnology ETF is in the black, with a year-to-date gain of 13.5% as of ...

Article found on: www.barrons.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up